✦ LIBER ✦

Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma

✍ Scribed by Barbara Pro; Brian Leber; Mitchell Smith; Luis Fayad; Jorge Romaguera; Fredrick Hagemeister; Alma Rodriguez; Peter McLaughlin; Felipe Samaniego; James Zwiebel; Adriana Lopez; Larry Kwak; Anas Younes

Book ID: 108675965
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 168 KB
Volume: 143
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07353.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oral fludarabine in co

Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma

✍ Kensei Tobinai; Ken-ichi Ishizawa; Michinori Ogura; Kuniaki Itoh; Yasuo Morishim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 955 KB

Phase II study of a salvage regimen usin

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Gemcitabine, dexamethasone, and cisplati

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma : A Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)

✍ Michael Crump; Tara Baetz; Stephen Couban; Andrew Belch; Deborah Marcellus; Kang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views